2821 Dalakas, Marinos - Thomas Jefferson University - Thomas Jefferson University
mcd003

Marinos C. Dalakas, MD, FAAN

Contact Dr. Dalakas

901 Walnut Street
4th Floor
Philadelphia, PA 19107

(215) 955 -7865
(215) 955-9976 fax

Most Recent Peer-reviewed Publications

  1. Viruses in IBM: Hit-and-run, hide and persist, or irrelevant?
  2. Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity
  3. Efficacy of Intravenous Immunoglobulin in Neurological Diseases
  4. Progressive encephalomyelitis with rigidity and myoclonus (PERM): Brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab
  5. Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future
  6. Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
  7. Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease
  8. Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse
  9. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis
  10. Pathogenesis of immune-mediated neuropathies
  11. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  12. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  13. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  14. Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4
  15. Inflammatory muscle diseases inflammatory muscle diseases
  16. Lower extremity peak force and gait kinematics in individuals with inclusion body myositis
  17. Future perspectives in target-specific immunotherapies of myasthenia gravis
  18. Reliability of the adult myopathy assessment tool in individuals with myositis
  19. Intravenous immunoglobulin in neurology-mode of action and clinical efficacy
  20. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders
0